搜尋結果
Info. Mydrin-P. / / Concise Prescribing Info. Contents. Per mL Tropicamide 5 mg, phenylephrine HCl 5 mg. Indications/Uses. Mydriasis & cycloplegia for the purpose of diagnosis or treatment. Click to view Mydrin-P detailed prescribing information. Dosage/Direction for Use.
As an adjunct to diet, alone or in combination w/ other lipid-lowering therapies (eg, statins, ezetimibe), for the treatment of adults w/ primary hyperlipidemia to reduce LDL-C. Click to view Praluent detailed prescribing information. Dosage/Direction for Use.
Primal. Concise Prescribing Info. Contents. Theophylline. Indications/Uses. Continuous symptomatic treatment of persistent asthma & of other forms of COPD. Dosage/Direction for Use. Adult Initially 5-8 mg/kg/day. Usual effective dose: 7-12 mg/kg/day. Max: 800 mg/day. Childn 9-16 yr Initially 10-12 mg/kg/day. Usual effective dose: 10-16 mg/kg/day.
Symptomatic treatment of allergic rhino-conjunctivitis (seasonal & perennial) & urticaria. 20 mg tab For adult & adolescents ≥12 yr. 10 mg orodispersible tab (ODT) For childn 6-11 yr w/ body wt of at least 20 kg. Click to view Labixten detailed prescribing information. Dosage/Direction for Use. Adult & adolescent ≥12 yr 20 mg tab once daily.
Info. Cosyr (Reformulated)咳敏消. Manufacturer: United Laboratories. Distributor: Unam. Concise Prescribing Info. Contents. Per 5 mL Dextromethorphan HBr 10 mg, chlorpheniramine maleate 1 mg. Indications/Uses. Cough in cold, flu, TB, bronchitis, bronchial asthma, pertussis, measles, pneumonia, excessive smoking, psychogenic cough.
MIMS.com is the leading online source of drug information, interactions, images, dosage and side effects for healthcare professionals in Malaysia and beyond. Whether you are looking for the latest medical news, updates on clinical guidelines, or comprehensive drug databases, MIMS.com has it all. Join millions of users who trust MIMS.com as their essential medical reference.
Info. NEW. Olumiant. baricitinib. / Concise Prescribing Info. Contents. Baricitinib. Indications/Uses. Monotherapy or in combination w/ MTX for the treatment of moderate to severe active RA in adults who have responded inadequately to, or who are intolerant to ≥1 DMARDs.
